European Medicines Agency, Amsterdam, the Netherlands
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
Documents
Agenda of the PRAC meeting 28 November - 1 December 2022